2Li CR, Chung YC, Park TW, et al. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first- line antipsychotic drug[ J]. World J Biol Psychiatry, 2009,10 (4 Pt 3) :919-924.
3De Lucena D, Fernandes BS, Berk M, et al. Improvement of negative and positive symptoms in treatment-refractory schizo phrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine [J]. Clin Psy- chiatry ,2009,70 ( 10 ) : 1416 -1423.
4Haas M, Unis AS, Armenteros J, et al. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia [J]. Child Adolesc Psychopharmacol,2009,19 (6) :611-621.
5De la Gandara J, San Molina L, Rubio G,et al. Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia:the SPHERE Study[ J]. Expert Rev Neurother,2009,9 ( 10 ) : 1463-1474.
6Hawley C, Turner M, Latif MA, et al. Switching stable patients with schizophrenia from depot and oral antipsychotics to longacting injectable risperidone:reasons for switching and safety [ J]. Hum Psychopharmacol,2009,25 ( 1 ) :37-46.
7Hori H, Ueda N, Yoshimura R, et al. Olanzapine orally disintegrating tablets (Zyprexa Zydis )rapidly improve excitement components in the acute phase of first-episode schizophrenic patients:an open-label prospective study [ J ]. World J Biol Psychiatry,2009,10 (4 Pt 3 ) :741-745.
8Kramer M, Litman R, Hough D. Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study [ J ]. Int J Neuropsychopharmacol,2010, 13 : 635-647.
9Bishara D, Taylor D. Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder [ J ]. Neuropsychiatr Dis Treat,2010,13(5) :635-647.
10Grootens KP, Van Veelen NM, Peuskens J, et al. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial[ J ]. Schizophr Bull,2011,37 (2) :352-361.
